Biomarker Research

Featured: Fibronectin protein expression in renal cell carcinoma

Carcinogenesis is a multistep process which involves interplay between the tumour cells and the matrix proteins. This occurs by adherence between the tumour cells and proteins in the extracellular matrix. VHL mutation affects through the hypoxia inducible factor (HIF) and causes changes in various tissue proteins like VEGF, PDGF, TGF, Fibronectin and others. In this research article, Kondisetty et al. aim to to quantify the changes of fibronectin protein in renal cell carcinoma tissue.

Content type: Research
| 17 September 2018

Aptamer-based search for correlates of plasma and serum water T₂: implications for early metabolic dysregulation and metabolic syndrome

Authors: Vipulkumar Patel, Alok K. Dwivedi, Sneha Deodhar, Ina Mishra and David P. Cistola
Content type: Rapid communication
| 23 August 2018

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL

Authors: Huining Kang, Nitesh D. Sharma, Christian K. Nickl, Meenakshi Devidas, Mignon L. Loh, Stephen P. Hunger, Kimberly P. Dunsmore, Stuart S. Winter and Ksenia Matlawska-Wasowska
Content type: Research
| 9 August 2018

Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia

Authors: Austin B. Henslee and Timothy A. Steele
Content type: Research
| 27 July 2018

Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

Authors: Michelle X. Yang, Ryan F. Coates, Abiy Ambaye, Juli-Anne Gardner, Richard Zubarick, Yuan Gao, Joan Skelly, James G. Liu and Mari Mino-Kenudson
Content type: Letter to the Editor
| 18 July 2018

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma

Authors: Hiroo Katsuya, Lucy B. M. Cook, Aileen G. Rowan, Yorifumi Satou, Graham P. Taylor and Charles R. M. Bangham

Most recent articles RSS

View all articles

Content type: Research
| 7 April 2016

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer

Authors: Elisabeth Hofmann, Rita Seeboeck, Nico Jacobi, Peter Obrist, Samuel Huter, Christian Klein, Kamil Oender, Christoph Wiesner, Harald Hundsberger and Andreas Eger
Content type: Review
| 1 April 2013

Metabolomic analyses for atherosclerosis, diabetes, and obesity

Authors: Fuyong Du, Anthony Virtue, Hong Wang and Xiao-Feng Yang
Content type: Review
| 7 January 2014

Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases

Authors: Jiyeon Yang, Lixiao Zhang, Caijia Yu, Xiao-Feng Yang and Hong Wang
Content type: Review
| 5 February 2013

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

Authors: Kai Zhu, Zhi Dai and Jian Zhou
Content type: Review
| 10 February 2014

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Authors: Ugo Testa, Elvira Pelosi and Arthur Frankel

Most accessed articles RSS

View all articles

Editors-in-Chief

Chung-Tsen Hsueh, Loma Linda University, USA

Delong Liu, New York Medical College, USA

Aims and scope

Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines.

The study of biomarkers has evolved rapidly in the advance of personalized medicine and individual health. The identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era. With a quick turnaround time from submission to publication and online feedback from readers, Biomarker Research strives to provide fast dissemination of novel findings and new knowledge.

Featured review: Cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Biomarker Research

Featured: Fibronectin protein expression in renal cell carcinoma

Articles

Aptamer-based search for correlates of plasma and serum water T₂: implications for early metabolic dysregulation and metabolic syndrome

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL

Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia

Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer

Metabolomic analyses for atherosclerosis, diabetes, and obesity

Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Editors-in-Chief

Aims and scope

Featured review: Cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

2017 Journal Metrics

Biomarker Research

Contact us